These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 14386278)

  • 1. [Significance of certain disorders of the central nervous system in pathogenesis of alloxan diabetes].
    SERAFIMOV V
    Suvr Med (Sofiia); 1954; 5(10):26-36. PubMed ID: 14386278
    [No Abstract]   [Full Text] [Related]  

  • 2. [Role of higher divisions of the central nervous system and sex hormones in the pathogenesis of experimental alloxan diabetes of young animals].
    SOKOLOVEROVA IM
    Probl Endokrinol Gormonoter; 1958; 4(4):77-83. PubMed ID: 13601623
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of functional disorders of the central nervous function on the course of alloxan diabetes].
    TUGARINOVA VN; CHUKHNINA IP
    Probl Endokrinol Gormonoter; 1958; 4(3):32-6. PubMed ID: 13567594
    [No Abstract]   [Full Text] [Related]  

  • 4. The importance of individual excitability of the CNS for the production of alloxan diabetes and its influence on central nervous functional state.
    Choinowski S; Hecht K; Baumann R
    Act Nerv Super (Praha); 1967 Aug; 9(3):314-5. PubMed ID: 6055618
    [No Abstract]   [Full Text] [Related]  

  • 5. [Histological and histochemical studies of the rat central nervous system following long-term alloxan diabetes].
    Woossmann H; Moritz V
    Dtsch Gesundheitsw; 1972 Sep; 27(38):1777-82. PubMed ID: 4635444
    [No Abstract]   [Full Text] [Related]  

  • 6. [Alterations in the neuraxon in alloxan diabetes; experimental study in the rabbit].
    LINOLI O
    Rass Studi Psichiatr; 1953; 42(5-6):797-826. PubMed ID: 13155906
    [No Abstract]   [Full Text] [Related]  

  • 7. [Role of the higher segments of the central nervous system, of the growth factor and of the sex hormones in the pathogenesis of experimental (alloxan) diabetes].
    SOKOLOVEROVA IM
    Tr Inst Fiziol Im I P Pavlova; 1959; 8():312-20. PubMed ID: 13832564
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of pharmacologic stimulation of the central nervous system on the course of alloxan diabetes].
    SMIRNOV NP
    Arkh Patol; 1954; 16(1):33-42. PubMed ID: 13149448
    [No Abstract]   [Full Text] [Related]  

  • 9. [Conditioned reflex induction of changes of glycemia in dogs in alloxan diabetes following pharmacological excitation of the central nervous system].
    SMIRNOV NP
    Probl Endokrinol Gormonoter; 1957; 3(3):64-71. PubMed ID: 13494447
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of the Ca2+ antagonist nimodipine on functional deficits in the peripheral and central nervous system of streptozotocin-diabetic rats.
    Biessels GJ; ter Laak MP; Kamal A; Gispen WH
    Brain Res; 2005 Feb; 1035(1):86-93. PubMed ID: 15713280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of neuroactive steroid levels by liquid chromatography-tandem mass spectrometry in central and peripheral nervous system: effect of diabetes.
    Caruso D; Scurati S; Maschi O; De Angelis L; Roglio I; Giatti S; Garcia-Segura LM; Melcangi RC
    Neurochem Int; 2008; 52(4-5):560-8. PubMed ID: 17686551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of saturated, monounsaturated, and polyunsaturated fatty acids on alloxan-induced diabetes mellitus.
    Suresh Y; Das UN
    Prostaglandins Leukot Essent Fatty Acids; 2006 Mar; 74(3):199-213. PubMed ID: 16412622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTPDase and 5'-nucleotidase activities in rats with alloxan-induced diabetes.
    Lunkes GI; Lunkes DS; Morsch VM; Mazzanti CM; Morsch AL; Miron VR; Schetinger MR
    Diabetes Res Clin Pract; 2004 Jul; 65(1):1-6. PubMed ID: 15163471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between lipid peroxidation processes, blood vessel wall changes and properties of erythrocytes in pathogenesis of microhemocirculation disorders during experimental diabetes mellitus].
    Kipiani VA; Katsadze MN; Delibashvili DG; Namoradze MSh; Kipiani NV
    Georgian Med News; 2006 Jan; (130):97-101. PubMed ID: 16510924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-Arginine ameliorates oxidative stress in alloxan-induced experimental diabetes mellitus.
    El-Missiry MA; Othman AI; Amer MA
    J Appl Toxicol; 2004; 24(2):93-7. PubMed ID: 15052603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of the age factor in the pathogenesis of experimentally induced alloxan diabetes].
    SOKOLOVEROVA IM
    Probl Endokrinol Gormonoter; 1958; 4(2):3-8. PubMed ID: 13554242
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of alloxan diabetes on certain inflammatory reactions of the rat].
    TURIAF J; JEANJEAN Y
    C R Seances Soc Biol Fil; 1956; 150(12):2128-9. PubMed ID: 13437542
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of streptozotocin-induced diabetes on the function of the central nervous system in rodents].
    Miyata S; Saitoh A; Hirano S; Kamei J
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2006 Apr; 26(2):83-7. PubMed ID: 16722465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysfunctional astrocytes as key players in the pathogenesis of central nervous system disorders.
    De Keyser J; Mostert JP; Koch MW
    J Neurol Sci; 2008 Apr; 267(1-2):3-16. PubMed ID: 17935736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antianemic effect of reamberin in rats with acute alloxan-induced diabetes].
    Volchegorskiĭ IA; Tishevskaia NV; Dement'eva EV
    Eksp Klin Farmakol; 2008; 71(6):23-7. PubMed ID: 19140511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.